In short. That order changes the outcome, that more modalities do more, and that one step can be credited with the result: claims the evidence does not carry.
Key points
- A plan built from findings has a length determined by the findings.
- A programme built first has findings fitted to it.
- The two look similar on a page and are different in a consultation, and the question that separates them is what happens if a step is removed.
Three claims about sequenced treatment are made routinely, and the evidence does not carry any of them. Each fails for a different reason, and the reasons are worth knowing separately.
That order changes the outcome
This claim is graded as limited. There is reasoning behind treating some things before others: some treatments make other findings easier to see, some change the tissue in a way that affects what a later step can do, and some require a longer recovery than others. The reasoning is not foolish. What does not exist is a study comparing one order with another and measuring a final appearance, so an order presented as established has been presented as more than it is.
That more modalities produce more
There is no dose-response relationship here. A face with three distinct findings may reasonably be treated with three modalities, and a face with one finding treated with three modalities has had two unnecessary procedures. The number of modalities is a consequence of the number of findings, and a programme that treats the number as an input has reversed the relationship.
Findings first, programme second
A plan built from findings has a length determined by the findings. A programme built first has findings fitted to it. The two look similar on a page and are different in a consultation, and the question that separates them is what happens if a step is removed.
That each step can be credited with its part of the result
This is the advantage sequencing claims over combining, and it holds only when the practice behind it does. If each step is judged before the next begins, against a standardised record, the effect of that step is visible. If the intervals are short, or the reviews are informal impressions, the effects run together and the attribution is lost. The claim is therefore conditional rather than wrong, and the condition is checkable: ask when the result of each step was assessed and against what.
That a programme can be fixed in advance
A sequence is a plan with a direction, not a schedule to be executed. Its advantage is that each step informs the next, which means the plan must be allowed to change. A programme that continues unchanged regardless of what the earlier steps produced has given up the only benefit sequencing has over treating everything at once, and has kept all of the cost.
Claims the evidence does not carry
- That one order of treatments has been shown to produce a better result than another.
- That more modalities, or a longer programme, produces more improvement.
- That a sequence can be planned once and followed without revision.
Each is stated with confidence, and none is established.
Frequently asked questions
Has the order of treatments been shown to change the result?
No. Comparing one order with another would need comparable groups followed long enough to judge an appearance, and that study has not been run. A preferred order may rest on good reasoning about healing and visibility, and reasoning is not a measurement. Order is graded as limited for that reason.
Why can the effect of each step not always be told apart?
Because the intervals may be too short or the reviews too informal. If a step is judged before the next begins and against a standardised record, its effect is visible. If the steps overlap or the reviews are impressions made while the next appointment is booked, the effects run together and the attribution that sequencing was supposed to provide is lost.
Does a longer programme produce more improvement?
Not established. There is no relationship between the number of treatments a person has and the quality of the outcome. Adding a modality adds its risks and its healing time, and it may make the earlier steps harder to assess. A programme justified by its length has been justified by its own size.
Risks & Limitations
- Sequencing separates treatments in time, which is not the same as combining them in one episode; the two are different strategies.
- Each component is approved on its own indication, and no regulator approves a sequence or fixes the interval between treatments.
- That a preferred order changes the outcome, and that more modalities produce more, are not established by the evidence.
- A sequence is a plan with a direction rather than a schedule, and its advantage is lost if the plan cannot change.
- A sequence lowers the burden on the tissue at any one moment; it does not lower the total, and the healing time adds up.
When to Seek Care
- Increasing pain, spreading redness or warmth, or a fever after any treatment — have it assessed urgently.
- Blistering, crusting or an open area that does not settle after a device treatment — have it assessed by a clinician.
- Pigment that darkens or spreads beyond the treated area over the following weeks — have it assessed by a clinician.
- A change in vision, speech or skin colour after an injectable — seek emergency care immediately.
References & Further Reading
- U.S. Food and Drug Administration (FDA) — approved products, devices and their labelled indications
- National Medical Products Administration (NMPA, China) — approved products and their indications
- National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
- Cochrane Library — systematic reviews of laser, light and injectable treatment
- Chinese Medical Association Plastic Surgery Branch — clinical guidance
This page is a review of published evidence and regulation, not medical advice, and it does not cite individual studies. It is not a booking page and it does not recommend a treatment. Discuss your own case with a qualified clinician. To ask a question about this review, see Contact & Consultation.